1 enrolling by invitation, 1 terminated, 1 unknown. 1 Early Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Opipramol: new trials by email Literature Review of Opipramol trials Research Report on Opipramol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Selected Disorders and Sleep Bruxism Opipramol - Sleep Bruxism, Hypertension | Enrolling by invitation | Wroclaw Medical University | 100 | 2017-04-20 | 2026-03-06 | |
| Double Blind Placebo Control Opipramol-Baclofen Treatment for Addiction Opipramol, Baclofen - Drug Abuse | Early Phase 1 | Unknown | Ministry of Health, Israel | 140 | 2017-03-01 | 2017-02-28 |
| Pharmacovigilance in Gerontopsychiatric Patients Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression | Phase 3 | Terminated | Hannover Medical School | 407 | 2015-01-01 | 2018-02-28 |
Anxiety Disorders (1) · Cardiovascular Diseases (1) · Dementia (1) · Depression (1) · Hypertension (1) · Psychophysiologic Disorders (1) · Schizophrenia (1) · Sleep Apnea Syndromes (1) · Sleep Bruxism (1) · Sleep Wake Disorders (1) · Substance-Related Disorders (1) · Temporomandibular Joint Disorders (1)
Hannover Medical School (1) · Ministry of Health, Israel (1) · Wroclaw Medical University (1)
Germany (1) · Israel (1) · Poland (1)
Gal Yadid, PhD (1) · Helena Martynowicz, M.D., Ph.D. (1) · Helge Frieling, Prof., MD (1) · Mieszko Wieckiewicz, D.M.D., Ph.D. (1)
PMID 30915015, PMID 31139138, PMID 32035303, PMID 32160378, PMID 41914053